Effect of acute administration of hydroalcohol extract of Ilex paraguariensis St Hilaire (Aquifoliaceae) in animal models of Parkinson's disease

Phytotherapy Research

Volumn 21, Issue 8, 2007, Pages 771-776

  Milioli, E M ^a   Cologni, P ^a   Santos, C C ^a   Marcos, T D ^a   Yunes, V M ^a   Fernandes, M S ^a   Schoenfelder, T ^a   Costa Campos, L ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Adenosine; Antioxidant; Ethnopharmacology; MPTP; Reserpine

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ADENOSINE A2A RECEPTOR; ALCOHOL; APOMORPHINE; DEOXYRIBOSE; ILEX PARAGUARINESIS EXTRACT; NITRIC OXIDE; PLANT EXTRACT; RESERPINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN PROTECTION; CATALEPSY; CATATONIA; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG ISOLATION; ETHNOPHARMACOLOGY; ILEX PARAGUARIENSIS; MALE; MOUSE; NONHUMAN; PARKINSON DISEASE;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; DISEASE MODELS, ANIMAL; HYDROXYL RADICAL; ILEX PARAGUARIENSIS; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; PARKINSONIAN DISORDERS; PLANT EXTRACTS; RESERPINE;

ANIMALIA; AQUIFOLIACEAE; ILEX PARAGUARIENSIS; MUS;

EID: 34547691107     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2166     Document Type: Article

References (30)

1. Appleman JR, Erion MD. 1998. The therapeutic potential of agents acting via purine receptors. Expert Opin Invest Drugs 7: 225-243.
2. Azam S, Hadi N, Khan NU, Hadi SM. 2003. Antioxidant and prooxidant properties of caffeine, theobromine and xanthine. Med Sci Monit 9: BR335-BR330.
3. Bartholomew B. 1984. A rapid method for the assay of nitrate in urine using the nitrate reductase enzyme of Escherichia coli. Food Chem Toxicol 22: 541-543.
4. Bixby M, Spieler L, Menini T, Gugliucci A. 2005. Ilex paraguariensis extracts are potent inhibitors of nitrosative stress: A comparative study with green tea and wines using a protein nitration model and mammalian cell cytotoxicity. Life Sci 77: 345-358.
5. Chen JF, Xu K, Petzer JP et al. 2001. Neuroprotection by caffeine and A2a adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci 21: RC143(1-6).
6. Cortopassi G, Wang E. 1995. Modelling the effects of age related mtDNA mutation accumulation; complex I deficiency, superoxide and cell death. Biochim Biophys Acta 1271: 171-176.
7. Filip R, Lopéz SB, Giberti G, Coussio J, Ferraro G. 2001. Phenolic compounds in seven South American Ilex species. Fitoterapia 72: 774-778.
8. Gerlach M, Riederer P. 1996. Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm 103: 987-1041.
9. Giasson BI, Ischiropoulos H, Lee VM, Trojanowski JQ. 2002. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases. Free Radic Biol Med 32: 1264-1275.
10. Good PF, Hsu A, Werner P, Perl DP, Olanow CW. 1998. Protein nitration in Parkinson's disease. J Neuropathol Exp Neurol 57: 338-342.
11. Halliwell B, Gutteridge JMC. 1981. Formation of a thiobarbituric-acid- reactive substance from deoxyribose in the presence of iron salts - the role of superoxide and hydroxyl radicals. FEBS Lett 128: 347-352.
12. Jenner P. 2003. A2A antagonists as novel nondopaminergic therapy for motor dysfunction in PD. Neurology 61(Suppl 6): S32-S38.
13. Jenner P, Olanow CW. 2006. The pathogenesis of cell death in Parkinson's disease. Neurology 66(10 Suppl 4): S24-S36.
14. Keeney PM, Xie J, Capaldi RA, Bennett JP Jr. 2006. Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 26: 5256-5264.
15. Lunceford N, Gugliucci A. 2005. Ilex paraguariensis extract inhibits AGE formation more efficiently than green tea. Fitoterapia 76: 419-427.
16. Mazzafera P. 1997. Mate drinking: caffeine and phenolic acid intake. Food Chem 60: 67-71.
17. Mensor L, Menezes GGL, Reis A, Santos T, Coube CS, Leitão S. 2001. Screening of Brazilian plants extracts for the antioxidant activity by the use of DPPH free radical method. Phytother Res 15: 127-130.
18. Pierri M, Vaudano E, Sager T, Englund U. 2005. KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse. Neuropharmacology 48: 517-524.
19. Popoli P, Caporali MG, Scotti CA. 1991. Akinesia due to catecholamine depletion in mice is prevented by caffeine. Further evidence for an involvement of adenosinergic system in the control of motility. J Pharm Pharmacol 43: 280-281.
20. 2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends Pharmacol Sci 18: 338-344.
21. Ross GW, Abbott RD, Petrovitch H et al. 2000. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 283: 2674-2679.
22. Schapira AH. 2006. Etiology of Parkinson's disease. Neurology 66(10 Suppl 4):S10-S23.
23. Schinella GR, Troiani G, Dávila V, Busciazzo PM, Tourner AA. 2000. Antioxidant effects of an aqueous extract of Ilex paraguariensis. Biochem Biophys Res Commun 269: 360-367.
24. Schmidt N, Ferger B. 2001. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease. Synapse 40: 47-54.
25. Schwarzschild MA, Xu K, Oztas E et al. 2003. Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson's disease. Neurology 61(11 Suppl 6): S55-S61.
26. Shiozaki S, Ichikawa S, Nakamura J, Kitamura S, Yamada K, Kuwana Y. 1999. Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP. Psychopharmacology 147: 90-95.
27. Singleton VL, Orthofer R, Lamuela-Raventos RM. 1999. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteau Reagent. Methods Enzymol 299: 152-178.
28. Smeyne RJ, Jackson-Lewis V. 2005. The MPTP model of Parkinson's disease. Brain Res Mol Brain Res 134: 57-66.
29. 2A receptors. Prog Neurobiol 59: 355-396.
30. Tsao R, Deng Z. 2004. Separation procedures for naturally occurring antioxidant phytochemicals. J Chromatogr 812: 85-99.